About the Study

Cystic Fibrosis: A clinical trial of combination study drug therapy (VX-121/TEZ/D-IVA)

This is a clinical study to learn more about the safety and tolerability of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in patients with Cystic Fibrosis. This study is open to patients who are 6 -11 years old. A clinical trial is a way to study new drugs and treatments to see if they are safe. VX-121/TEZ/D-IVA is the combination study treatment that is being used for this study and is an investigational drug. "Investigational" means the drug is not approved by the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA) in the European Union or health authorities in other countries and is still being tested for safety and effectiveness.

Interested in learning more?

Full Study Name: VX21-121-105